Vincerx Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	13.64	18.89	22.58	3.6	0
Research & Development	28.97	49.84	40.08	7.12	0
Other Operating Expenses	0	2.47	0	0	0
Operating Expenses	42.61	71.19	62.66	10.71	0
Operating Income	-42.61	-71.19	-62.66	-10.71	-0
Other Expense / Income	-2.45	-8.21	-23.35	5.91	-
Pretax Income	-40.16	-62.98	-39.31	-16.62	-0
Net Income	-40.16	-62.98	-39.31	-16.62	-0
Shares Outstanding (Basic)	21	21	17	5	1
Shares Outstanding (Diluted)	21	21	17	5	1
Shares Change	1.26%	22.43%	227.04%	320.16%	-
EPS (Basic)	-1.89	-3.00	-2.29	-3.16	-
EPS (Diluted)	-1.89	-3.00	-2.29	-3.16	-
Free Cash Flow	-40.45	-59.6	-38.66	-2.28	0
Free Cash Flow Per Share	-1.90	-2.83	-2.25	-0.43	-
EBITDA	-39.24	-62.05	-38.97	-16.62	-0
Depreciation & Amortization	0.92	0.94	0.34	0	0
EBIT	-40.16	-62.98	-39.31	-16.62	-0

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).